NANO-EW

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNANO-EW
Drug Alias NameSN-38 (Nanovalent/Children's Hospital of Los Angeles)NANO-EW
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitorsTransferrins modulators
TargetsTransferrinsDNA topoisomerase I
Therapy Area/IndicationsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanovalent Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChildren'S Hospital Los AngelesNanovalent Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSarcoma, Ewing

Other Information

ATC CodeN/A
Related LinksN/A